The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Direct Link Between mhc Polymorphism, T Cell Avidity, and Diversity in Immune Defense
Abstract
Major histocompatibility complex ( mhc )–encoded molecules govern immune responses by presenting antigenic peptides to T cells. The extensive polymorphism of genes encoding these molecules is believed to enhance immune defense by broadening the array of antigenic peptides available for T cell recognition, but direct evidence supporting the importance of this mechanism in combating pathogens is limited. Here we link mhc polymorphism - driven diversification of the cytotoxic T lymphocyte (CTL) repertoire to the generation of high-avidity, protective antiviral T cells and to superior antiviral defense. Thus, much of the beneficial effect of the mhc polymorphism in immune defense may be due to its critical influence on the properties of the selected CTL repertoire.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L., & Wiley, D. C. (1987) · Nature · doi:10.1038/329512a0 · Cited by 2,377
Common West African HLA antigens are associated with protection from severe malaria
Hill, A. V. S., Allsopp, C. E. M., Kwiatkowski, D., Anstey, N. M., Twumasi, P., Rowe, P. A., Bennett, S., Brewster, D., McMichael, A. J., & Greenwood, B. M. (1991) · Nature · doi:10.1038/352595a0 · Cited by 1,552
HLA and HIV-1: Heterozygote Advantage and B*35-Cw*04 Disadvantage
Carrington, M., Nelson, G. W., Martin, M. P., Kissner, T., Vlahov, D., Goedert, J. J., Kaslow, R., Buchbinder, S., Hoots, K., & O'Brien, S. J. (1999) · Science · doi:10.1126/science.283.5408.1748 · Cited by 1,224
The Biochemistry and Cell Biology of Antigen Processing and Presentation
Germain, R. (1993) · Annual Review of Immunology · doi:10.1146/annurev.immunol.11.1.403 · Cited by 1,020
Herpes simplex virus turns off the TAP to evade host immunity
Hill, A., Jugovic, P., York, L., Russ, G., Bennink, J., Yewdell, J., Ploegh, H., & Johnson, D. (1995) · Nature · doi:10.1038/375411a0 · Cited by 803
Herpes simplex virus turns off the TAP to evade host immunity
(1995) · Trends in Genetics · doi:10.1016/0168-9525(95)90181-7 · Cited by 736
MHC heterozygosity confers a selective advantage against multiple-strain infections
Penn, D. J., Damjanovich, K., & Potts, W. K. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162006499 · Cited by 668
A viral inhibitor of peptide transporters for antigen presentation
Früh, K., Ahn, K., Djaballah, H., Sempé, P., van Endert, P. M., Tampé, R., Peterson, P. A., & Yang, Y. (1995) · Nature · doi:10.1038/375415a0 · Cited by 602
Liu, T., Khanna, K. M., Chen, X., Fink, D. J., & Hendricks, R. L. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.9.1459 · Cited by 385
Evolution of Class-I MHC Genes and Proteins: From Natural Selection to Thymic Selection
Lawlor, D. A., Zemmour, J., Ennis, P. D., & Parham, P. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.000323 · Cited by 310
Cited by
Immune checkpoint therapy—current perspectives and future directions
Sharma, P., Goswami, S., Raychaudhuri, D., Siddiqui, B. A., Singh, P., Nagarajan, A., Liu, J., Subudhi, S. K., Poon, C., Gant, K. L., et al. (2023) · Cell · doi:10.1016/j.cell.2023.03.006 · Cited by 1,206
The many important facets of T-cell repertoire diversity
Nikolich-Žugich, J., Slifka, M. K., & Messaoudi, I. (2004) · Nature Reviews Immunology · doi:10.1038/nri1292 · Cited by 675
Self-citationSARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition
Nelde, A., Bilich, T., Heitmann, J. S., Maringer, Y., Salih, H. R., Roerden, M., Lübke, M., Bauer, J., Rieth, J., Wacker, M., et al. (2021) · Nature Immunology · doi:10.1038/s41590-020-00808-x · Cited by 582
Britanova, O. V., Putintseva, E. V., Shugay, M., Merzlyak, E. M., Turchaninova, M. A., Staroverov, D. B., Bolotin, D. A., Lukyanov, S., Bogdanova, E. A., Mamedov, I. Z., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302064 · Cited by 465
Yager, E. J., Ahmed, M., Lanzer, K., Randall, T. D., Woodland, D. L., & Blackman, M. A. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071140 · Cited by 490
Genomic correlates of response to immune checkpoint blockade
Keenan, T. E., Burke, K. P., & Van Allen, E. M. (2019) · Nature Medicine · doi:10.1038/s41591-019-0382-x · Cited by 448
CD8+ T cell efficacy in vaccination and disease
Appay, V., Douek, D. C., & Price, D. A. (2008) · Nature Medicine · doi:10.1038/nm.f.1774 · Cited by 393
Improved Survival with T Cell Clonotype Stability After Anti–CTLA-4 Treatment in Cancer Patients
Cha, E., Klinger, M., Hou, Y., Cummings, C., Ribas, A., Faham, M., & Fong, L. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008211 · Cited by 383
Structural determinants of T-cell receptor bias in immunity
Turner, S. J., Doherty, P. C., McCluskey, J., & Rossjohn, J. (2006) · Nature Reviews Immunology · doi:10.1038/nri1977 · Cited by 369
Confronting Complexity: Real-World Immunodominance in Antiviral CD8+ T Cell Responses
Yewdell, J. W. (2006) · Immunity · doi:10.1016/j.immuni.2006.09.005 · Cited by 364
Schultheiß, C., Paschold, L., Simnica, D., Mohme, M., Willscher, E., von Wenserski, L., Scholz, R., Wieters, I., Dahlke, C., Tolosa, E., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.024 · Cited by 333
A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity
Heitmann, J. S., Bilich, T., Tandler, C., Nelde, A., Maringer, Y., Marconato, M., Reusch, J., Jäger, S., Denk, M., Richter, M., et al. (2022) · Nature · doi:10.1038/s41586-021-04232-5 · Cited by 255
Specificity of T-cell alloreactivity
Felix, N. J., & Allen, P. M. (2007) · Nature Reviews Immunology · doi:10.1038/nri2200 · Cited by 254
Wang, G. C., Dash, P., McCullers, J. A., Doherty, P. C., & Thomas, P. G. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003647 · Cited by 238
Estimating T-cell repertoire diversity: limitations of classical estimators and a new approach
Laydon, D. J., Bangham, C. R. M., & Asquith, B. (2015) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2014.0291 · Cited by 215
Human memory T cells with a naive phenotype accumulate with aging and respond to persistent viruses
Pulko, V., Davies, J. S., Martinez, C., Lanteri, M. C., Busch, M. P., Diamond, M. S., Knox, K., Bush, E. C., Sims, P. A., Sinari, S., et al. (2016) · Nature Immunology · doi:10.1038/ni.3483 · Cited by 175
Self-citationReproducible selection of high avidity CD8 + T-cell clones following secondary acute virus infection
Cukalac, T., Chadderton, J., Handel, A., Doherty, P. C., Turner, S. J., Thomas, P. G., & La Gruta, N. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323736111 · Cited by 39
“Collectively, this has the biological advantage of a recall response with enhanced function while maintaining TCR diversity, shown to be beneficial for virus control (4, 6) and for retaining the plasticity to respond to viral escape mutants (3, 5).”
Background
Metadata
- Authors
- Messaoudi, I., Patiño, J. A. G., Dyall, R., LeMaoult, J., & Nikolich-Žugich, J.
- Venue
- Science
- Published
- 2002-11-29
- Volume
- 298
- Issue
- 5599
- Pages
- 1797-1800
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2060354653
- Cited by
- 323
- References
- 24
- FWCI
- 3.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.